Remdesivir prices slashed by pharma cos after govt intervention, details here

New Delhi: Remdesivir, one among the life saving drugs for Coronavirus, has become more accessible to people with its prices being slashed by several pharma companies.

The price of Remdesivir injection is now reduced after government’s intervention.

National Pharmaceutical Pricing Authority in an office memorandum said, major Pharma companies have announced voluntary price cuts for Remdesivir Injections after Centre’s intervention to ensure it’s affordable availability.

Earlier & Current Rates here:

Cadila Healthcare’s Remdac will now cost Rs. 899 instead of Rs. 2,800.

Syngene International’s RemWin will now cost Rs. 2,450 instead of Rs. 3,950.

Dr Reddy’s Redyx will be available at Rs. 2, 700 instead of Rs. 5,400.

Cipla’s Cipremi will cost Rs. 3,000 instead of Rs. 4000.

Mylan Pharmaceutical’s Desrem will be available at Rs. 3,400 instead of Rs. 4,800.

Jubilant Generic’s Jubi-R will now cost Rs. 3,400 instead of Rs. 4,700.

Hetero Healthcare’s Covifor will be available at Rs. 3490 instead of Rs. 5,400.